Transglutaminase 2 expression is associated with increased risk of lymph node metastasis and recurrence in papillary thyroid cancer
Endocrine · 2023
DOI: 10.1007/s12020-023-03427-2 ↗Kurz gefasst
Fachartikel in der Zeitschrift Endocrine, 2023. Verfasst von Yagmur Goksoy Solak und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey. yagmurgoksoy@gmail.com. Hauptthemen laut MEDLINE: Thyroid Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 31 Literaturangaben.
Abstract (Originalsprache)
PURPOSE: Transglutaminase 2 (TG2) is associated with mobilization, invasion, and chemoresistance of tumor cells. We aimed to determine whether the immunohistochemical staining with TG2 antibody differs between metastatic and non-metastatic papillary thyroid cancer patients. METHODS: We included 76 patients with papillary thyroid cancer (72% female, median age 52 (24-81) years, follow-up time 107 (60-216) months). Thirty of them with no metastasis, 30 of them with only lymph node metastasis and 16 patients with distant ± lymph node metastasis. Immunohistochemical staining of TG2 antibody was evaluated in the primary tumor and extra-tumoral tissue. We also divided subjects into two groups according to their primary tumor TG2 staining score (group A, high risk group: ≥3, n = 43; group B, low risk group:
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Internal Medicine, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey. yagmurgoksoy@gmail.com.
- Department of Pathology, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey.
- Department of Endocrinology and Metabolism, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey.
Zitieren
APA
Goksoy Solak, Y., Yegen, G., Onder, S., Tekin, S., Soyluk, O., Gul, N., Tanakol, R., Aral, F., & Kubat Uzum, A. (2023). Transglutaminase 2 expression is associated with increased risk of lymph node metastasis and recurrence in papillary thyroid cancer. Endocrine. https://doi.org/10.1007/s12020-023-03427-2
Vancouver
Goksoy Solak Y, Yegen G, Onder S, Tekin S, Soyluk O, Gul N, et al. Transglutaminase 2 expression is associated with increased risk of lymph node metastasis and recurrence in papillary thyroid cancer. Endocrine. 2023. doi:10.1007/s12020-023-03427-2
BibTeX
@article{GoksoySolak2023,
author = {Goksoy Solak, Yagmur and Yegen, Gulcin and Onder, Semen and Tekin, Sakin and Soyluk, Ozlem and Gul, Nurdan and Tanakol, Refik and Aral, Ferihan and Kubat Uzum, Ayse},
title = {Transglutaminase 2 expression is associated with increased risk of lymph node metastasis and recurrence in papillary thyroid cancer},
journal = {Endocrine},
year = {2023},
doi = {10.1007/s12020-023-03427-2}
}
EUVIMED